Jump Main Menu. Go directly to the main content

Sección de idiomas


Fin de la sección de idiomas

Access / Registration

Sección de utilidades

Fin de la sección de utilidades



Start of main content

Impact of omic sciences on Medicine, Nutrition and Biotechnology

Life and Matter Sciences International Symposium March 29, 2016 Madrid

General information

Venue: Fundación Ramón Areces Vitruvio, 5 28006 Madrid

Organized by:

Fundación Ramón Areces

In cooperation with:

Royal National Academy of Medicine and the BioEuroLatina Association


Albert SassonPresident of BioEuroLatina. Madrid. Spain

  • Description
  • Programme

Since the publication of the human genome in 2003, much was expected from possible applications in the field of medicine and more generally a better understanding of human physiology including nutrition and pathology. We now start to collect more knowledge about human genes and the effects of mutations, for example in the field of cancer. In fact, advances have gone beyond knowledge of human genome, epigenome and transcriptome. Science has advanced as well in the knowledge of human proteome and metabolome. The advance in this so-called Omic Sciences have led to the development of diagnostic and therapeutic tools which enable what we call today Precision Medicine.

This Simposyum is sponsored by the Fundación Ramón Areces under the auspices of the Royal National Academy of Medicine and the BioEuroLatina Association. It brings together scientists involved in many ways for the bettering of public health.

Tuesday, 29


Welcome and venue presentation

Federico Mayor Zaragoza
Chairman, Scientific Council. Fundación Ramón Areces.

Joaquín Poch Broto
President,  Real Academia Nacional de Medicina. Spain. 

Albert Sasson
President of BioEuroLatina. Madrid. Spain.

Carmen Vela 
Secretary of State for Competitiveness and Innovation. MINECO. Spain.


The impact of omics sciences on public health and health systems

José María Martín-Moreno
Professor of Medicine and Public Health, Universidad de Valencia. Spain.


Omics revolution in human health

Bertrand De Meulder
Instituto Europeo para Sistemas Biológicos y Medicina. Lyon. France.


Cancer therapies: more precise personalized approaches

Ana Ramírez de Molina
IMDEA Alimentación. Madrid. Spain.




Metabolomics applied to precision medicine

John Ryals
Metabolon Inc. Durham. North Carolina. USA.


Nutrigenomics, bringing precision to nutritional advice

José María Ordovás
Tufts University. Boston. USA.


Antibiotic resistance genes: the intestinal resistome

Fernando Baquero
Hospital Universitario Ramón y Cajal. Madrid. Spain.


Microbiome for human health

Hervé Blottière
Instituto Nacional de Investigación Agronómica (INRA). Jouy en Josas. France.




Session opened to: European companies involved in bringing precision medicine from the laboratory to clinical applications

Óscar Rodríguez
Patia Biopharma.

Lavinia Ionita
Omixy Ltd.

Thomas Wilckens
Innventis Ltd. 

Eric Lameignere

Lorena Muñoz
BioEurolatina. Madrid. Spain.


Debate: Precision medicine: challenges and promises

Pedro Albert Sasson
Presidente de BioEuroLatina. Madrid.

Federico Mayor Zaragoza
Presidente del Consejo Científico. Fundación Ramón Areces.




A new golden era for medical and pharmaceutical biotechnology: are we fulfilling the promises of the sequencing of the human genome?

Albert Sasson
President of BioEuroLatina. Madrid. Spain.

Federico Mayor Zaragoza
Chairman, Scientific Council. Fundación Ramón Areces.

  • Activities related
  • Projects related
  • News related
  • Publications related

see all

End of main content